Recent Articles from Anthony Vecchione
NJEDA offers support to customers impacted by COVID-19
The moves from the agency aim to improve cash flow and conserve capital for portfolio companies.
Rutgers launches doctorate of Public Health Degree Program
The 48-credit hybrid degree program features online courses supplemented with face-to-face meetings.
Garden State Pharmacy Owners association names executive director
The independent pharmacist replaces Marty Miller, who headed the organization since 2014.
Cytosorbents appoints chief medical officer
Dr. Efthymios Deliargyris most recently served in the same position for Sparta-based specialty pharmaceutical company PLx Pharma.
Hackensack Meridian releases study of hypertension’s impact on COVID-19
To date, the health care system has cared for more than 3,000 patients with confirmed infections and is currently treating over 1,800 at its hospitals.
J&J collaboration to expand COVID-19 vaccine candidate manufacturing
"Our collaboration with Emergent is proof that we are moving quickly to deliver on that promise [to deliver more than one billion doses worldwide],” said Dr. Paul Stoffels, vice chairman of the executive committee and chief scientific officer for Johnson & Johnson.
COVID-19 saliva-based testing from Rutgers begins rollout across NJ
According to Rutgers Biomedical and Health Sciences Chancellor Brian Strom, the development has the potential to test 10,000 people per day.
HPAE files OSHA complaint over Virtua Health’s distribution of defective PPE
"We can say, unequivocally, that this complaint is not true," the Marlton-based provider said of the claims from the state's largest union of nurses and health care professionals on behalf of workers in Mount Holly.
NJ hospitals required to report COVID-19 demographic data
“Understanding the impact of COVID-19 by demographic group is critical to ensure equity in our response to this virus,” the governor said. “We must do everything we can to protect the most vulnerable groups in our state during this unprecedented crisis. This data will inform our efforts and allow us to make sure that no one is left behind.”
Quest Diagnostics begins COVID-19 antibody testing
Laboratory capacity is expected to expand from approximately 70,000 per day by the end of this week to approximately 150,000 a day by early-May.
Zeus Scientific unveils rapid SARs-CoV-2 antibody test
A request for Emergency Use Authorization is under review by the U.S. Food and Drug Administration; if approved the medical manufacturer expects the test to be available for customers in early May 2020.
NJ biotech company receives FDA approval for breast cancer drug
Morris Plains-based Immunomedics, Inc. a biopharmaceutical company specializing in antibody-drug conjugates (ADC), announced Wednesday that the U.S. Food and Drug Administration has approved Trodelv (sacituzumab govitecan-hziy) for the treatment of adult […]
















